Vascular News editorial board members Nicholas Inston (Birmingham, UK; CX executive board member) and Bart Dolmatch (Palo Alto, USA) are joined by Kate Steiner (Stevenage, UK; CX executive board member) to share their expert insights on a range of topics, including:
- Limus drugs
- The future of endoAVF
- New data on high-flow fistulas
The panel also preview highlights from the upcoming CX 2025 Vascular Access Masterclass, including a Great Debate on the motion ‘drug-coated balloons (DCBs) should not be the standard of care’.
